These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5121461)

  • 21. Cancer immunology: some basic concepts.
    Klein G
    Transplant Proc; 1980 Dec; 12(4):661-5. PubMed ID: 6971005
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression of Epstein-Barr nuclear antigen 2 in kidney tubule cells induce tumors in transgenic mice.
    Törnell J; Farzad S; Espander-Jansson A; Matejka G; Isaksson O; Rymo L
    Oncogene; 1996 Apr; 12(7):1521-8. PubMed ID: 8622868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
    Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
    Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of allograft rejection of the conceptus.
    Breyere EJ; Sprenger WW
    Transplant Proc; 1969 Mar; 1(1):71-5. PubMed ID: 5406844
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunogenicity of various forms of H-2 antigens as detected by the growth rate of an allogeneic tumour.
    Hilgert I; Kristofová H; Stoyanov S
    Folia Biol (Praha); 1971; 17(6):353-9. PubMed ID: 5136931
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inhibition of the growth of a syngeneic weakly immunogenic tumor in mice resulting from exposures affecting T lymphocyte activity].
    Babadzhanov AS; Buntsevich AM
    Biull Eksp Biol Med; 1983 Apr; 95(4):69-71. PubMed ID: 6338967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of the specific transplantation tumour antigen in carcinoma BO-IV in vivo.
    Rejthar A; Wotke J
    Neoplasma; 1971; 18(1):27-31. PubMed ID: 5575433
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coombs-positive reactions in mice during transplantation of syngeneic tumors].
    Buntsevich AM; Mikheeva NV
    Biull Eksp Biol Med; 1983 May; 95(5):81-4. PubMed ID: 6850095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
    Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
    Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal carcinosarcoma. Ultrastructure and transplantation into athymic mice.
    Cecil B; Woodard B; Mickey DD; Pizzo S
    Arch Pathol Lab Med; 1980 May; 104(5):276-9. PubMed ID: 6892761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of tumor site on the therapy of murine kidney cancer.
    Chakrabarty A; Hillman GG; Maughan RL; Visscher DW; Ali E; Pontes JE; Haas GP
    Anticancer Res; 1994; 14(2A):373-8. PubMed ID: 8017836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour-distinctive cellular immunity to renal carcinoma.
    Stjernswärd J; Almgård LE; Franzén S; von Schreeb T; Wadström LB
    Clin Exp Immunol; 1970 Jun; 6(6):963-8. PubMed ID: 5477730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous decrease of tumor-specific antigenicity and "hybrid effect" in a murine methylcholanthrene-induced sarcoma.
    Oth D; Donner M; Burg C
    Transplantation; 1969 Nov; 8(5):742-5. PubMed ID: 5403331
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma.
    Svensson HP; Frank IS; Berry KK; Senter PD
    J Med Chem; 1998 Apr; 41(9):1507-12. PubMed ID: 9554883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and characterization of human renal cancer cell lines and autologous normal kidney short term cultures.
    Schattka S; Decken K; Schmitz-Dräger B; Ackermann R; Ebert T
    Investig Urol (Berl); 1994; 5():35-41. PubMed ID: 7719318
    [No Abstract]   [Full Text] [Related]  

  • 39. [Can monoclonal antibodies to a carcinoma-specific cell surface molecule prevent liver metastasis of human colorectal carcinoma and effectively treat already existing micrometastases?].
    Burkart C; Porschen R
    Z Gastroenterol; 1996 Jan; 34(1):41-2. PubMed ID: 8776175
    [No Abstract]   [Full Text] [Related]  

  • 40. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
    J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.